BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24048456)

  • 21. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
    He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
    PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1.
    Wang J; Wang B; Ren H; Chen W
    Biochem Biophys Res Commun; 2019 Jan; 509(1):241-248. PubMed ID: 30591220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
    Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
    Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ING5 suppresses breast cancer progression and is regulated by miR-24.
    Cui S; Liao X; Ye C; Yin X; Liu M; Hong Y; Yu M; Liu Y; Liang H; Zhang CY; Chen X
    Mol Cancer; 2017 May; 16(1):89. PubMed ID: 28490335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH.
    Chen Z; Ma Y; Pan Y; Zhu H; Yu C; Sun C
    Mol Cell Probes; 2018 Aug; 40():19-26. PubMed ID: 29908229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma.
    Li H; Xiang H; Ge W; Wang H; Wang T; Xiong M
    Int J Clin Exp Pathol; 2015; 8(10):12313-8. PubMed ID: 26722418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
    Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
    Qin Y; Dang X; Li W; Ma Q
    Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
    Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
    J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing.
    Belvedere R; Saggese P; Pessolano E; Memoli D; Bizzarro V; Rizzo F; Parente L; Weisz A; Petrella A
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism.
    Wu DH; Liang H; Lu SN; Wang H; Su ZL; Zhang L; Ma JQ; Guo M; Tai S; Yu S
    Cell Physiol Biochem; 2018; 50(3):924-935. PubMed ID: 30355947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1.
    Wang P; Chen L; Zhang J; Chen H; Fan J; Wang K; Luo J; Chen Z; Meng Z; Liu L
    Oncogene; 2014 Jan; 33(4):514-24. PubMed ID: 23334332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propofol suppresses proliferation and invasion of pancreatic cancer cells by upregulating microRNA-133a expression.
    Wang ZT; Gong HY; Zheng F; Liu DJ; Dong TL
    Genet Mol Res; 2015 Jul; 14(3):7529-37. PubMed ID: 26214431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.
    Vorvis C; Hatziapostolou M; Mahurkar-Joshi S; Koutsioumpa M; Williams J; Donahue TR; Poultsides GA; Eibl G; Iliopoulos D
    Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1124-37. PubMed ID: 27151939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
    Ishiwata T; Matsuda Y; Yamamoto T; Uchida E; Korc M; Naito Z
    Am J Pathol; 2012 May; 180(5):1928-41. PubMed ID: 22440254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
    Shang Y; Wang LQ; Guo QY; Shi TL
    Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-released exosomal circular RNA PDE8A promotes invasive growth via the miR-338/MACC1/MET pathway in pancreatic cancer.
    Li Z; Yanfang W; Li J; Jiang P; Peng T; Chen K; Zhao X; Zhang Y; Zhen P; Zhu J; Li X
    Cancer Lett; 2018 Sep; 432():237-250. PubMed ID: 29709702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [MiR-150-5p inhibits the proliferation and promoted apoptosis of pancreatic cancer cells].
    Sun Y; Jin XL; Zhang TT; Jia CW; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):460-4. PubMed ID: 24246865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
    Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.